InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $201.340 1.06 (0.52%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$96,620 CSL Annual Report 2018/19 6 Sep 2019 8:54AM $239.650 $201.340 fallen by 15.99%
$96,620 Change of Director's Interest Notice 30 Aug 2019 2:08PM $239.920 $201.340 fallen by 16.08%
$96,620 Change of Director's Interest Notice 30 Aug 2019 2:07PM $239.920 $201.340 fallen by 16.08%
$96,620 Appendix 3B 27 Aug 2019 3:35PM $233.930 $201.340 fallen by 13.93%
$96,620 Change of Director's Interest Notice 23 Aug 2019 2:08PM $237.820 $201.340 fallen by 15.34%
$96,620 Update - Dividend/Distribution - CSL 14 Aug 2019 3:04PM $234.100 $201.340 fallen by 13.99%
$96,620 Dividend/Distribution - CSL 14 Aug 2019 8:22AM $219.500 $201.340 fallen by 8.27%
$96,620 CSL Results Presentation 14 Aug 2019 8:21AM $219.500 $201.340 fallen by 8.27%
$96,620 CSL Results Announcement 14 Aug 2019 8:21AM $219.500 $201.340 fallen by 8.27%
$96,620 CSL Full Year Statutory Accounts for the Year Ended 30/06/19 14 Aug 2019 8:20AM $219.500 $201.340 fallen by 8.27%
$96,620 Notice of 2019 Full Year Result meeting 6 Aug 2019 9:07AM $226.450 $201.340 fallen by 11.09%
$96,620 Anjana Narain to Lead Seqirus Influenza Vaccines Business 17 Jul 2019 8:23AM $222.590 $201.340 fallen by 9.55%
$96,620 UPDATE ON CSL TRANSITION TO OWN DISTRIBUTOR MODEL IN CHINA 21 Jun 2019 8:58AM $219.460 $201.340 fallen by 8.26%
$96,620 Appendix 3B 4 Jun 2019 10:15AM $205.660 $201.340 fallen by 2.10%
$96,620 Shareholder Information Meetings 28 May 2019 9:21AM $206.650 $201.340 fallen by 2.57%
$96,620 Appointmet of Chief Operating Officer 16 May 2019 8:28AM $200.840 $201.340 risen by 0.25%
$96,620 Appendix 3B 14 May 2019 11:48AM $198.390 $201.340 risen by 1.49%
$96,620 Notice of Shareholder Information Meetings 8 May 2019 11:17AM $197.440 $201.340 risen by 1.98%
$96,620 Seqirus Presentation at 2019 Macquarie Equities Conference 30 Apr 2019 8:31AM $198.140 $201.340 risen by 1.62%
$96,620 Appendix 3B 2 Apr 2019 3:23PM $200.235 $201.340 risen by 0.55%
$96,620 Appendix 3B 12 Mar 2019 4:52PM $198.610 $201.340 risen by 1.37%
$96,620 Change of Director's Interest Notice 21 Feb 2019 4:42PM $185.500 $201.340 risen by 8.54%
$96,620 Update - Dividend/Distribution - CSL 20 Feb 2019 9:40AM $184.000 $201.340 risen by 9.42%
$96,620 Appendix 3B 19 Feb 2019 9:32AM $187.040 $201.340 risen by 7.65%
$96,620 Dividend/Distribution - CSL 13 Feb 2019 8:53AM $193.690 $201.340 risen by 3.95%

626 - 650 of 1201 results

Page 26 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.